SGI
DGX icon

Summit Global Investments’s Quest Diagnostics DGX Stock Holding History

Summit Global Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,833
Closed -$303K – 235
2019
Q4 		$303K Buy
2,833
+177
+7% +$18.5K 0.03% 258
2019
Q3 		$284K Buy
2,656
+115
+5% +$11.8K 0.03% 262
2019
Q2 		$259K Buy
2,541
+130
+5% +$12.5K 0.03% 273
2019
Q1 		$217K Sell
2,411
-434
-15% -$37.6K 0.03% 270
2018
Q4 		$237K Sell
2,845
-42,330
-94% -$3.97M 0.04% 246
2018
Q3 		$4.88M Buy
45,175
+3,989
+10% +$438K 0.65% 54
2018
Q2 		$4.53M Buy
41,186
+13,292
+48% +$1.38M 0.68% 54
2018
Q1 		$2.8M Buy
27,894
+16,314
+141% +$1.67M 0.45% 56
2017
Q4 		$1.14M Buy
11,580
+1,897
+20% +$180K 0.18% 85
2017
Q3 		$907K Buy
9,683
+5,083
+111% +$540K 0.14% 93
2017
Q2 		$511K Buy
4,600
+500
+12% +$52.9K 0.15% 148
2017
Q1 		$403K Buy
+4,100
New +$391K 0.13% 183

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Summit Global Investments's DGX Position: Q1 2020 in Review

Summit Global Investments sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 2,833 shares — an estimated $303K sold.

Summit Global Investments first reported a position in DGX in Q1 2017 and held it in 12 quarters. The position peaked at $4.88M in Q3 2018. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

  • Summit Global Investments reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
  • Summit Global Investments sold 2,833 Quest Diagnostics shares in Q1 2020, an estimated $303K.
  • Summit Global Investments first reported a position in Quest Diagnostics in Q1 2017 and held it in 12 quarters.
  • Summit Global Investments's Quest Diagnostics position peaked at $4.88M in Q3 2018.
  • 714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Summit Global Investments's 13F filing for Q1 2020, filed 14 May 2020.